Bearish
Prime Medicine (PRME) Reports Q1 EPS
Prime Medicine, Inc. (NASDAQ:PRME) reported its Q1 2026 earnings, with an EPS of (28c) against a consensus of (25c), and revenue of $856,000. CEO Alla...
PRME
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (0)
Neutral (0)
Bearish (1)
Latest PRME News
Bearish
Research PRME on:
Ad Space